Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients

Autor: Ela Hayati, Ahmad Rizal Ganiem, Vycke Yunivita, Rovina Ruslami, Reinout van Crevel, Atu Purnama Dewi, Rob E. Aarnoutse, Petra Meijerhof-Jager, Sofiati Dian, Tri Hanggono Achmad, Marga Teulen

Publikováno v: International Journal of Antimicrobial Agents, 48, 4, pp. 415-21
International Journal of Antimicrobial Agents, 48, 415-21

Contains fulltext : 171178.pdf (Publisher’s version ) (Closed access) High-dose intravenous (i.v.) rifampicin improved the outcome of tuberculous meningitis (TBM) in a previous study. Unfortunately, i.v. rifampicin is not available in many high-end

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d4f8b1ee41e3c338f29ee0044651b4b
https://pubmed.ncbi.nlm.nih.gov/27526979